Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• TaeBSKimJKKangMPrognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patientsSci Rep201771138028469275
   PubMedGoogle Scholar
• Lopez-BeltranAMontironiRNon-invasive urothelial neoplasms: according to the most recent WHO classificationEur Urol200446217017615245809
   PubMed Web of Science ®Google Scholar
• KangMJeongCWKwakCKimHHKuJHPreoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumorOncotarget201788128911290128039452
   PubMedGoogle Scholar
• CambierSSylvesterRJColletteLEORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-GuerinEur Urol2016691606926210894
   PubMed Web of Science ®Google Scholar
• Zamanian-DaryoushMDiDonatoJAApolipoprotein A-I and cancerFront Pharmacol2015626526617517
   PubMed Web of Science ®Google Scholar
• ChangSJHouMFTsaiSMThe association between lipid profiles and breast cancer among Taiwanese womenClin Chem Lab Med20074591219122317663634
   PubMed Web of Science ®Google Scholar
• BorgquistSButtTAlmgrenPApolipoproteins, lipids and risk of cancerInt J Cancer2016138112648265626804063
   PubMed Web of Science ®Google Scholar
• KimYWBaeSMLimHKimYJAhnWSDevelopment of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkersPLoS One201279e4496022970327
   PubMed Web of Science ®Google Scholar
• van DuijnhovenFJBueno-De-MesquitaHBCalligaroMBlood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and NutritionGut20116081094110221383385
   PubMed Web of Science ®Google Scholar
• ClarkeCHYipCBadgwellDProteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerGynecol Oncol2011122354855321708402
   PubMed Web of Science ®Google Scholar
• NosovVSuFAmneusMValidation of serum biomarkers for detection of early-stage ovarian cancerAm J Obstet Gynecol20092006639e631e63519285648
   PubMed Web of Science ®Google Scholar
• Tuft StavnesHNymoenDAHetland FalkenthalTEKaernJTropeCGDavidsonBAPOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survivalAm J Clin Pathol20141421515724926085
   PubMed Web of Science ®Google Scholar
• QuanQHuangYChenQImpact of serum apolipoprotein A-I on prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer: a propensity score-matched analysisTransl Oncol201710228829428292509
   PubMed Web of Science ®Google Scholar
• GuoSHeXChenQThe effect of preoperative apolipoprotein A-I on the prognosis of surgical renal cell carcinoma: a retrospective large sample studyMedicine (Baltimore)20169512e314727015197
   PubMed Web of Science ®Google Scholar
• JiangRYangZHLuoDHElevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinomaMed Oncol20143188025023050
   PubMed Web of Science ®Google Scholar
• WenWJChenMKQinZKSerum apolipoprotein A-1 predicts superior prognosis in upper tract urothelial carcinoma after rapid surgeryChin J Endourol (Electronic Edition)201603193197 Chinese [with English abstract].
   Google Scholar
• Zamanian-DaryoushMLindnerDTallantTCThe cardioprotective protein apolipoprotein A-1 promotes potent anti-tumorigenic effectsJ Biol Chem201328829212372125223720750
   PubMed Web of Science ®Google Scholar
• SuFKozakKRImaizumiSApolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancerProc Natl Acad Sci U S A201010746199972000221041624
   PubMed Web of Science ®Google Scholar
• ManoRBanielJShoshanyONeutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancerUrol Oncol201533267e61e67
   Web of Science ®Google Scholar
• BrausiMWitjesJALammDA review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer GroupJ Urol201118662158216722014799
   PubMed Web of Science ®Google Scholar
• Hajian-TilakiKReceiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluationCaspian J Intern Med20134262763524009950
   PubMedGoogle Scholar
• KoKParkYHLeeJWKuJHKwakCKimHHInfluence of nutritional deficiency on prognosis of renal cell carcinoma (RCC)BJU Int2013112677578024028765
   PubMed Web of Science ®Google Scholar
• CuiJYuMZhangNPrognostic scores based on the preoperative plasma fibrinogen and serum albumin level as a prognostic factor in patients with upper urinary tract urothelial carcinomaOncotarget2017840689646897328978171
   PubMedGoogle Scholar
• LisCGGrutschJFVashiPGLammersfeldCAIs serum albumin an independent predictor of survival in patients with breast cancer?JPEN J Parenter Enteral Nutr2003271101512549592
   PubMed Web of Science ®Google Scholar
• BabjukMBohleABurgerMEAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016Eur Urol201771344746127324428
   PubMed Web of Science ®Google Scholar
• CamontLChapmanMJKontushABiological activities of HDL subpopulations and their relevance to cardiovascular diseaseTrends Mol Med2011171059460321839683
   PubMed Web of Science ®Google Scholar
• DegomaEMRaderDJNovel HDL-directed pharmacotherapeutic strategiesNat Rev Cardiol20118526627721243009
   PubMed Web of Science ®Google Scholar
• LibbyPRidkerPMHanssonGKProgress and challenges in translating the biology of atherosclerosisNature2011473734731732521593864
   PubMed Web of Science ®Google Scholar
• WangXPLiXHZhangLHigh level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinomaBMC Cancer20161651627444612
   PubMed Web of Science ®Google Scholar
• QuanQChenQChenPDecreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal typeOnco Targets Ther201691281129027051293
   PubMed Web of Science ®Google Scholar
• LuoXLZhongGZHuLYSerum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinomaOncotarget2015641440374404826503474
   PubMedGoogle Scholar
• GanapathyESuFMeriwetherDD-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSODInt J Cancer201213051071108121425255
   PubMed Web of Science ®Google Scholar
• GaoFChattopadhyayANavabMApolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1alpha in human ovarian cancer cell lines and a mouse ovarian cancer modelJ Pharmacol Exp Ther2012342225526222537771
   PubMed Web of Science ®Google Scholar
• GaoFVasquezSXSuFL-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathwaysIntegr Biol (Camb)20113447948921283904
   PubMed Web of Science ®Google Scholar
• LiCLiHZhangTLiJLiuLChangJDiscovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysisBiochem Biophys Res Commun201444641047105224661883
   PubMed Web of Science ®Google Scholar
• BrachaSMcNamaraMHilgartIA multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urineAnal Biochem2014455414724704347
   PubMed Web of Science ®Google Scholar
• LeiTZhaoXJinSMengQZhouHZhangMDiscovery of potential bladder cancer biomarkers by comparative urine proteomics and analysisClin Genitourin Cancer2013111566222982111
   PubMed Web of Science ®Google Scholar
• FrantziMvan KesselKEZwarthoffECDevelopment and validation of urine-based peptide biomarker panels for detecting bladder cancer in a multi-center studyClin Cancer Res201622164077408627026199
   PubMed Web of Science ®Google Scholar
• CaiWKongWDongBPretreatment serum prealbumin as an independent prognostic indicator in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors as first-line target therapyClin Genitourin Cancer2017153e437e44628188047
   PubMed Web of Science ®Google Scholar
• ShavvaVSMogilenkoDANekrasovaEVTumor necrosis factor alpha stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-kappaB, and nuclear receptors PPARalpha and LXRsMol Cell Biochem Epub2018213
   PubMed Web of Science ®Google Scholar
• PengMZhangQChengYApolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progressionOncotarget2017859996939970629245934
   PubMedGoogle Scholar
• AljaberyFOlssonHGimmOJahnsonSShaboIM2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancerUrol Oncol Epub20171226
   PubMed Web of Science ®Google Scholar
• KarlAGrimmTJokischFGaisaNTStiefCGNichtmuskelinvasives Harnblasenkarzinom: Aktuelles zu Diagnoseverfahren, lokalen Therapieoptionen und zum Update der WHO-Klassifikation 2016. [Non-muscle invasive bladder cancer: Current aspects of diagnostics, local therapy options and the update of the 2016 WHO classification]Urologe A201655912471258 German [with English abstract]27518790
   PubMedGoogle Scholar
• ChengLMontironiRLopez-BeltranATERT promoter mutations occur frequently in urothelial papilloma and papillary urothelial neoplasm of low malignant potentialEur Urol201771349749828040359
   PubMed Web of Science ®Google Scholar
• MbeutchaAShariatSFRiekenMPrognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancerUrol Oncol20163411483.e417e483.e424
   Web of Science ®Google Scholar
• SylvesterRJOosterlinckWHolmangSSystematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-T1 urothelial carcinoma of the bladder: which patients benefit from the instillation?Eur Urol201669223124426091833
   PubMed Web of Science ®Google Scholar